MedTrace Logo

Technical Evaluation of Brahms PCT Direct

NCT01771029 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2014-12-12

No results posted yet for this study

Summary

Validation of the technical performance of the BRAHMS PTC direct point-of-care assay under routine conditions with native patient samples. The clinical validation is planned as a method comparison to a reference method (BRAHMS PCT sensitive KRYPTOR, Elecsys BRAHMS PCT). The study hypothesis is to show a highest correlation between the new product and the reference methods.

Conditions

Sponsors & Collaborators

  • Thermo Fisher Scientific, Inc

    collaborator INDUSTRY

  • Philipp Schuetz

    lead OTHER

Principal Investigators

  • Philipp Schuetz, PD, Dr.med. · Kantonsspital Aarau

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2014-06-30
Completion
2014-09-30

Countries

  • France
  • Germany
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01771029 on ClinicalTrials.gov